S-Adenosylmethionine.

5-methyltetrahydrofolate donates the methyl group that regenerates methionine from homocysteine, and methionine is what the cell converts into SAM-e. Supplying the folate form keeps the cycle turning instead of draining it.

Methionine synthase needs cobalamin to move the methyl group from folate onto homocysteine. Without B12 alongside, added methyl demand from SAM-e use pushes homocysteine up rather than back to methionine.

Betaine remethylates homocysteine through BHMT, a route independent of folate and B12. It gives the methionine cycle a second lane when SAM-e turnover is high.

Cystathionine beta-synthase and cystathionine gamma-lyase both run on pyridoxal-5-phosphate, and those are the enzymes that clear homocysteine downstream of SAM-e use. B6 lets the sulfur carbon exit toward cysteine rather than accumulate.

Phosphatidylethanolamine methylation consumes SAM-e to make phosphatidylcholine, and dietary choline spares that demand. Choline also feeds betaine, so the two pools trade methyl groups back and forth.

Sulfur leaving the methionine cycle through transsulfuration becomes cysteine, the rate-setting building block of glutathione. SAM-e is also the allosteric activator that opens that branch.

NAC supplies cysteine directly, which relieves pressure on the transsulfuration branch that SAM-e turnover loads. The two arrive at the same glutathione pool from different ends of the pathway.

Methionine adenosyltransferase, the enzyme that builds SAM-e from methionine and ATP, is magnesium dependent. Magnesium also partners nearly every ATP-handling step around it.

MTHFR carries an FAD cofactor derived from riboflavin, and MTHFR makes the methylfolate that feeds methionine regeneration. Low riboflavin narrows the folate arm of the cycle.

Methionine adenosyltransferase condenses methionine with ATP to form S-adenosylmethionine, transferring the whole adenosyl group and releasing all three phosphates. Methionine supply and ATP supply are the two direct inputs to that reaction. This is the single most direct precursor relationship the molecule has.

Guanidinoacetate methyltransferase methylates guanidinoacetate to creatine and is one of the largest single consumers of SAMe-derived methyl groups in the body. Supplying creatine directly reduces how much endogenous synthesis is called for, which spares methyl groups for other methyltransferases. The methyl-sparing logic is established biochemistry; the size of the effect varies with intake and habitual diet.

Nicotinamide N-methyltransferase methylates excess nicotinamide to N1-methylnicotinamide for excretion, and that reaction consumes SAMe and generates S-adenosylhomocysteine. Large nicotinamide intakes therefore draw on the same methyl pool. This is a real competition for methyl groups rather than a formulation preference.

Phosphatidylethanolamine N-methyltransferase in the liver adds three successive methyl groups from SAMe to make phosphatidylcholine, which makes it another heavy methyl consumer. Dietary phosphatidylcholine reduces the demand on that route. The relationship runs in both directions depending on which supply is short.

Once SAMe donates its methyl group it becomes S-adenosylhomocysteine and then homocysteine, which can be carried through cystathionine to cysteine by the transsulfuration limb. SAMe itself allosterically activates cystathionine beta-synthase, the committed step of that limb. Cysteine is the rate-limiting input for glutathione synthesis downstream.

Cysteine generated through transsulfuration is oxidised by cysteine dioxygenase and decarboxylated toward taurine. SAMe sits upstream of that flow as the activator of the transsulfuration branch. The connection is a metabolic route, not a measured combined effect.

Sulfite oxidase, which carries a molybdenum cofactor, oxidises sulfite to sulfate at the end of the transsulfuration route that SAMe feeds. Without adequate molybdenum that terminal step is limited. This is a cofactor requirement rather than an additive effect.

Betaine homocysteine methyltransferase is a zinc metalloenzyme, and the zinc thiolate centre is what activates the homocysteine thiol for methyl transfer. That enzyme is the betaine-dependent route for regenerating methionine and therefore SAMe. Zinc status is a structural requirement of the enzyme itself.

Carnitine synthesis begins with the trimethylation of protein-bound lysine, which uses three SAMe-derived methyl groups per molecule. Dietary carnitine reduces how much of that route is called on. It is another line item in the same methyl budget as creatine and phosphatidylcholine.

Acetylserotonin O-methyltransferase places the final methyl group on N-acetylserotonin to give melatonin, and that methyl comes from SAMe. Methyl group availability is therefore part of the final synthesis step. This describes the biochemistry and is not a claim about sleep measures.

Two O-methylation steps in coenzyme Q biosynthesis, carried out by COQ3, use SAMe as the methyl donor. Endogenous CoQ production therefore draws on the same methyl pool. The link is biosynthetic and does not imply that either raises the other's blood level.

Catechol-O-methyltransferase inactivates dopamine, noradrenaline and adrenaline by methylating a catechol hydroxyl group, using SAMe as donor. Tyrosine feeds the synthesis side of that same pool. Supplying both loads the two ends of one cycle, which is why the pairing needs care rather than being simply additive.

Decarboxylated SAMe donates an aminopropyl group to putrescine to make spermidine, and again to spermidine to make spermine, releasing 5-methylthioadenosine. This is the second major fate of SAMe, entirely separate from methyl transfer. The proportion of SAMe use that runs through this branch rather than through methylation is not quantified here.

Arginine and glycine combine to form guanidinoacetate, which is then methylated by SAMe to give creatine. Raising the supply of the precursors raises the pull on the methyl pool at the last step. This is methyl budget accounting rather than a synergy on any endpoint.

Glycine N-methyltransferase is the abundant hepatic enzyme that disposes of surplus methyl groups by converting glycine to sarcosine, and it is directly inhibited by 5-methyltetrahydrofolate. Glycine is also a precursor of guanidinoacetate. It functions as the overflow valve of the methyl economy in both roles.

The PEMT route, which uses SAMe methyl groups, preferentially produces phosphatidylcholine species enriched in long-chain polyunsaturated fatty acids used for lipoprotein export. Methyl availability and DHA supply therefore meet at hepatic phospholipid assembly. This is mechanistic and no combination measurement is cited here.

5-HTP is decarboxylated directly to serotonin, and SAMe is reported to influence monoamine turnover through its role in methylation. Stacking two agents that both act on the same neurotransmitter system without supervision is a caution to flag rather than a benefit to claim. Anyone taking serotonergic medication should raise this with a clinician first.

St John's wort influences monoamine reuptake and induces CYP3A4 and P-glycoprotein. Combining it with SAMe stacks two agents acting on the same neurotransmitter system, and the enzyme induction adds a separate layer that affects other products in the regimen. Flag this pairing rather than recommend it.

Tryptophan is the upstream precursor of serotonin, and SAMe is reported to affect monoamine turnover. Two agents acting on one neurotransmitter system belong in a clinician conversation rather than in a self-assembled stack. This row exists as a caution.

Methylenetetrahydrofolate reductase is a FAD-dependent flavoenzyme, and it produces the 5-methyltetrahydrofolate that methionine synthase needs to regenerate methionine. Riboflavin status therefore sets an upstream limit on how much SAMe can be resynthesised. The requirement is structural to the enzyme.